Center for Global Health R&D Policy Assessment

Follow us on:

Follow us on:

Featured Blog Post

Save the Date: Webinar on alternative models for global health R&D

The business of developing drugs, vaccines, and diagnostics for neglected disease is complex. Public and private product developers must navigate tough scientific challenges, identify financing options, explore uncertain markets, and establish wide-ranging collaborations to come up with promising technologies.